It is a pharma private limited company based in Pune, Maharashtra, India, established in 2018.
2018 | Pune, Maharashtra, India | ActiveGirraffe Pharmaceutical (India) Private Limited, a active private limited company, was established on 20 September 2018 in Pune, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74999PN2018PTC178904. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Prashant Nivrutti Shinde (Director), Samir Nivrutti Shinde (Director). Past directors included Prashant Nivrutti Shinde, Samir Nivrutti Shinde, Manisha Samir Shinde. It holds ₹1.20 M open charges and no settled loans. Its latest AGM occurred on 05 September 2025, with the balance sheet filed on 31 March 2025. It is based at A-24, Shivshakti Housing Society, Sahayog Nagar Talawade Nr Gavali School, Pune, Maharashtra, 411034.
U74999PN2018PTC178904
178904
20 September 2018
₹0.50 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Girraffe Pharmaceutical (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prashant Nivrutti Shinde | Director | 19 May 2023 | Current |
| Samir Nivrutti Shinde | Director | 19 May 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Nov 2020 | Past |
| Pramod Abcsdd | Director | 23 Nov 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Girraffe Pharmaceutical (India) Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 53.45% decrease. The company also saw a substantial fall in profitability, with a 80.71% decrease in profit. The company's net worth Soared by an impressive increase of 19.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Girraffe Pharmaceutical (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jan 2025 | Others | ₹1.20 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Girraffe Pharmaceutical (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Girraffe Pharmaceutical (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Girraffe Pharmaceutical (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Girraffe Pharmaceutical (India) Private Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records. was recorded as a recent event.
Girraffe Pharmaceutical (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 1.20 M with Charge ID 101053016 was registered on 04 Jan 2025. was documented.
Prashant Nivrutti Shinde was appointed as a Director was appointed as a Director on 19 May 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
Samir Nivrutti Shinde was appointed as a Director was appointed as a Director on 19 May 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
Girraffe Pharmaceutical (India) Private Limited was registered on 20 Sep 2018 with Roc Pune & aged 7 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Girraffe Pharmaceutical (India) Private Limited is U74999PN2018PTC178904.
Girraffe Pharmaceutical (India) Private Limited is headquartered at A-24, Shivshakti Housing Society, Sahayog Nagar Talawade Nr Gavali School, Pune, Maharashtra, 411034.
Girraffe Pharmaceutical (India) Private Limited was incorporated on 20 September 2018.
The current directors of Girraffe Pharmaceutical (India) Private Limited are
The primary industry of Girraffe Pharmaceutical (India) Private Limited is Pharma.
Girraffe Pharmaceutical (India) Private Limited is unlisted.
The authorized capital of Girraffe Pharmaceutical (India) Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX